Humana Inc.
HUMHumana is a scale player in senior health insurance, riding aging demographics but operating on margins under 2 percent.
Because in insurance, tiny margin shifts can mean the difference between compounding wealth and destroying it.
Business Model
Government-backed health plans
Humana collects premiums, mainly from Medicare Advantage plans, and pays members’ medical bills.
Economic Engine
Scale and risk pricing
Profit depends on accurately pricing risk and managing medical costs across millions of members.
Long-Term Lens
Margin resilience
The key question is whether sub 2 percent margins can stabilize or expand over decades.
BinaPrint Snapshot
Style
Harvest
Fitness
Stressed
Updated Mar 8, 2026
On this page
Company Story
How do Humana Inc.'s business model and economics hold up on a closer read?
Start with the business itself, then go one layer deeper into the model, the economics, and the long-term case.
“Humana has powerful demographic tailwinds, but razor-thin margins and weak cash conversion make it a fragile long-term compounder unless profitability improves.”
What does Humana Inc. actually do?
Humana sells health insurance plans, mostly to seniors enrolled in Medicare Advantage.
- Provides private Medicare Advantage plans as an alternative to traditional Medicare
- Collects monthly premiums from members and payments from the federal government
- Pays doctors, hospitals, and pharmacies for members’ medical care
Why it matters
Aging America is its fuel
As more Americans turn 65 each year, the pool of potential Medicare Advantage members steadily grows.
How does Humana Inc. make money?
Humana makes money by collecting more in premiums and government payments than it spends on medical claims and administration.
- Revenue has grown about 11.6 percent per year on average over five years
- Gross margin is 14.5 percent, but operating margin is just 1.1 percent
- Net profit margin sits at only 0.9 percent and has been contracting
Economic clue
Thin margins, little room for error
When your net margin is under 1 percent, even small cost spikes can wipe out profits.
Why do long-term investors keep Humana Inc. on the radar?
Humana sits at the crossroads of demographics and government healthcare spending, two forces that will shape the next 20 years.
- Revenue is still growing at 10.1 percent year over year
- Earnings per share have declined 18.9 percent per year on average over five years
- Free cash flow is only 0.32 times net income, signaling weak cash conversion
Investor takeaway
Growth without strong profits is fragile
Top-line growth alone does not create lasting value if margins and cash flow remain under pressure.
Based on company financial statements.
What Could Change The Story
- Broke would move the profile toward Yield.
- Turnaround complete would move the profile toward Vault.
Benchmark Comparison
How has Humana Inc. performed against common long-term benchmarks?
Once the business case is clear, compare the stock against broad market and alternative long-term baselines.
$448.56
-55.1% total return
$1,753
+75.3% total return
$2,975
+197.5% total return
$1,393
+39.3% total return
| Asset | Total Return | Dollar Value |
|---|---|---|
| HUM | -55.1% | $448.56 |
| S&P 500 | +75.3% | $1,753 |
| Gold | +197.5% | $2,975 |
| Bitcoin | +39.3% | $1,393 |
From Mar 5, 2021 to Mar 6, 2026. Historical price data based on company financial statements and market indices. Each card uses the same starting amount so the comparison stays apples-to-apples.
Investor Fit
How a first-time investor could frame Humana Inc.
Before going deeper, decide what kind of business this is, what it tends to suit, and what deserves monitoring over time.
This Can Fit If You Want
- Exposure to long-term growth in Medicare Advantage enrollment
- A business tied to essential healthcare spending rather than discretionary demand
- Potential upside if margins recover from depressed levels
Be Careful If You Expect
- High and stable profit margins
- Strong and consistent earnings per share growth
- Reliable dividend income, since dividends are currently zero
What To Watch Over Time
- Operating margin trend, currently just 1.1 percent and contracting
- Free cash flow compared to net income, now only 0.32 times
- Policy changes in Medicare reimbursement rates
BinaPrint Position
Where does Humana Inc. sit on the BinaPrint map right now?
Test whether business quality and financial profile match the company's stated narrative.
Advanced BinaPrint details
Open the axes, investor fit, and risk framing behind this profile.
Key Metrics
Which metrics matter most for Humana Inc. right now?
Three durable business metrics that matter more than day-to-day price moves.
11.6% average annual growth
-18.9% average annual decline
0.9% net margin
| Metric | Value | Context |
|---|---|---|
| Revenue Growth | 11.6% average annual growth | Shows whether the business has been expanding fast enough to create more long-term value. |
| EPS Growth | -18.9% average annual decline | Shows whether earnings per share are compounding for owners over time. |
| Margin Quality | 0.9% net margin | Shows how much room the business has to fund growth, absorb shocks, and stay profitable. |
Based on company financial statements.
Fundamentals
What do Humana Inc.'s fundamentals say right now?
Core financial markers that explain how the business is performing beneath the stock price.
9.1% ROIC
14.5% gross margin
0.3% FCF margin
Stable to shrinking
| Metric | Value | Interpretation |
|---|---|---|
| Capital Efficiency | 9.1% ROIC | The business is currently showing poor capital efficiency. |
| Profitability | 14.5% gross margin | Healthy gross margins give the company room to invest, price competitively, and absorb shocks. |
| Cash Generation | 0.3% FCF margin | Free cash flow margin shows how much real cash the business keeps after funding operations and investment. |
| Ownership Trend | Stable to shrinking | The company is not currently diluting owners and may be buying back shares instead. |
Based on company financial statements.
Included In Funds
Which ETFs and funds currently hold Humana Inc.?
Humana Inc. currently appears in these ETF and fund proxies.
SPY
SPDR S&P 500 ETF Trust
IWB
iShares Russell 1000 ETF
Questions & Answers
What questions come up most often about Humana Inc.?
Company-specific questions readers often ask about Humana Inc..
Each entry answers a direct question about the business, the long-term thesis, or the risks that matter over time.
Humana sells health insurance plans, mainly Medicare Advantage coverage for seniors, and manages their healthcare costs.
Decision Framing
Secondary context after the long-term thesis
Shorter-horizon context and comparison tools, after the core long-term read.
Shorter-horizon price moves, two-sided debate, and comparison tools live here so the page stays anchored on business quality, durability, and BinaPrint fit first.
Investment Thesis
Bull vs Bear
Two-sided framing before any decision.
Current argument weight is balanced.
Bull case
What can work
The aging of the U.S. population provides a steady flow of new Medicare-eligible seniors, supporting long-term enrollment growth.
Scale in Medicare Advantage allows better data analytics, care coordination, and negotiating leverage with providers over time.
If operating margins recover even from 1.1 percent to a few percentage points higher, earnings could grow much faster than revenue due to operating leverage.
Healthcare is a non-discretionary expense, making demand more resilient during economic downturns.
Bear case
What can break
Government policy changes to Medicare reimbursement rates could compress margins permanently in a business already earning under 1 percent net margin.
Medical cost inflation outpacing premium growth could structurally erode profitability over the next decade.
Competition from other large insurers could lead to pricing pressure and member churn, limiting pricing power.
Persistent weak cash conversion, currently 0.32 times net income, could constrain investment and shareholder returns.
Risk Radar
Key Risks
Where downside pressure can build.
Regulatory concentration, a large majority of revenue tied to Medicare Advantage, which depends on federal payment rates
Margin risk, net margin only 0.9 percent, so a 1 percentage point cost increase could eliminate profits
Cash flow risk, free cash flow only 0.3 percent of revenue, limiting financial flexibility
Pressure points
Concentration risk
Humana is heavily concentrated in Medicare Advantage, meaning a large share of revenue depends on federal government reimbursement formulas. Any structural change in Medicare policy or payment rates could have an outsized impact on profitability.
Sizing matters
Risks should be read as scenario inputs, not certainties. Position size and time horizon determine how much of this downside profile is acceptable.
Market Snapshot
Tactical context after the core long-term read.
- Price
- $179.15
- Daily move
- -0.89%
Peer Set
A compact peer list for side-by-side context.
Next Actions
Explore planning scenarios or keep browsing similar companies.